Bristol-Myers Squibb Co
BMYHealthcare|Drug Manufacturers - General|USA
$58.23
-1.10 (-1.85%)
DCF (FCF)
$68.81
Earnings Power
$30.07
Analyst Ratings
| Firm / Analyst | Rating | Price Target | Date |
|---|---|---|---|
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — |
Analyst Estimates
annual
{
"date": [
"202612",
"202712",
"202812"
],
"revenue_estimate": [
47099.57,
46139.92,
40602.34
],
"ebit_estimate": [
16350.45,
15997.45,
13837.04
],
"ebitda_estimate": [
17815.97,
17589,
15515.87
],
"net_income_estimate": [
12830.21,
12452.94,
10847.54
],
"per_share_eps_estimate": [
4.9,
5.05,
4.61
],
"eps_nri_estimate": [
6.27,
6.13,
5.35
],
"dividend_estimate": [
2.52,
2.6,
2.67
],
"book_value_per_share_estimate": [
11.42,
13.56,
16.86
],
"pretax_income_estimate": [
15636.02,
15127.17,
13437.36
],
"operating_cash_flow_per_share_estimate": [
7.01,
6.68,
6.48
],
"roa_estimate": [
12.7,
10.83,
9.75
],
"roe_estimate": [
59.35,
49.71,
38.37
],
"gross_margin_estimate": [
70,
70.66,
73.28
],
"operating_cash_flow_estimate": [
14300.73,
13612.36,
13205.99
],
"pettm_estimate": [
11.88,
11.53,
12.63
],
"long_term_growth_rate_mean": -4.29,
"long_term_revenue_growth_rate_mean": "-5.21",
"future_per_share_eps_estimate_growth": 9.33,
"future_eps_nri_estimate_growth": -4.29,
"future_revenue_estimate_growth": -5.21,
"future_ebit_estimate_growth": null,
"future_ebitda_estimate_growth": null,
"future_dividend_estimate_growth": 2.43,
"future_net_income_estimate_growth": null,
"future_pretax_income_estimate_growth": null,
"future_book_value_per_share_estimate_growth": 22.51,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": 1.01,
"future_operating_cash_flow_per_share_estimate_growth": -2.55
}
quarterly
{
"date": [
"202603",
"202606",
"202609",
"202612",
"202703",
"202706",
"202709",
"202712"
],
"revenue_estimate": [
10850.51,
11899.1,
12135.13,
12225.82,
10758.13,
11621.93,
11824.1,
12050.33
],
"ebit_estimate": [
3798.29,
4349.38,
4255.99,
3972.36,
3868.35,
4297.85,
4194.45,
4059.2
],
"ebitda_estimate": [
4173.76,
4771.79,
4673.18,
4383.2,
null,
null,
null,
null
],
"net_income_estimate": [
2945.65,
3411.41,
3318.54,
3101.24,
2972.05,
3306.15,
3161.65,
3052.25
],
"per_share_eps_estimate": [
1.15,
1.33,
1.3,
1.24,
1.07,
1.13,
1.07,
1.01
],
"eps_nri_estimate": [
1.45,
1.67,
1.63,
1.53,
1.48,
1.63,
1.59,
1.54
],
"dividend_estimate": [
null,
null,
null,
null,
0.65,
0.65,
0.65,
0.65
],
"book_value_per_share_estimate": [
null,
null,
8.45,
null,
null,
null,
null,
null
],
"pretax_income_estimate": [
3640.95,
4137.56,
4067.38,
3762.7,
3578.1,
4007.6,
3904.2,
3768.95
],
"operating_cash_flow_per_share_estimate": [
1.42,
2.45,
3.99,
null,
null,
null,
null,
null
],
"roa_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"roe_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"gross_margin_estimate": [
71.22,
70.53,
69.52,
67,
71.45,
71.3,
70.7,
70.2
],
"operating_cash_flow_estimate": [
2895.38,
4995.55,
8135.61,
null,
null,
null,
null,
null
],
"pettm_estimate": [
11.61,
11.79,
12.27,
12.9,
13.61,
null,
null,
null
],
"long_term_growth_rate_mean": -4.29,
"long_term_revenue_growth_rate_mean": "-5.21",
"future_per_share_eps_estimate_growth": 9.33,
"future_eps_nri_estimate_growth": -4.29,
"future_revenue_estimate_growth": -5.21,
"future_ebit_estimate_growth": null,
"future_ebitda_estimate_growth": null,
"future_dividend_estimate_growth": 2.43,
"future_net_income_estimate_growth": null,
"future_pretax_income_estimate_growth": null,
"future_book_value_per_share_estimate_growth": 22.51,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": 1.01,
"future_operating_cash_flow_per_share_estimate_growth": -2.55
}